Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

9:02 AM ET 10-Q
Financial Results Arbor Realty Trust Inc ABR

Arbor Realty Trust Q3 2026 Results: Net Loss of $82.4M

Arbor Realty Trust reported a net loss of $82.4 million for the third quarter of 2026, driven by significant increases in provisions for credit losses and impairment losses on real estate owned. The company also reduced its common stock dividend to $0.17 per share for the quarter, down from $0.30 in the prior year period.

Key figure
Net loss $82.4M
9:01 AM ET 8-K
Dividend Steele Creek Capital Corp

Steele Creek Capital Dividend

Steele Creek Capital Corporation's Board of Directors declared a cash dividend of $6.2020 per share on its common stock. The dividend is payable on November 2, 2026, to shareholders of record as of September 30, 2026.

9:00 AM ET 8-K
Leadership Change TechTarget, Inc. TTGT

TechTarget Leadership Change

Bill Morelli, President and General Manager of Intelligence & Advisory, has resigned from TechTarget for personal reasons. His resignation is expected to be effective December 31, 2026, and he will remain in his role until then to support an orderly transition.

9:00 AM ET 10-Q
Financial Results Allegro Microsystems, Inc. ALGM

Allegro Microsystems Q2 2026 Results: Net Income $23.3M, Up 256.8% YoY

Allegro MicroSystems reported a significant turnaround for the six-month period ended September 25, 2026, with net sales increasing to $536.1 million compared to $417.7 million in the prior year. The company achieved a net income of $39.2 million for the first half of the fiscal year, recovering from a net loss of $6.6 million in the same period of 2025.

Key figure
Net income $23.3M · +256.8% YoY
9:00 AM ET Form 4
Insider Buying Oncotelic Therapeutics, Inc. OTLC

Oncotelic Therapeutics Chairman and CEO Vuong Trieu Buys $17.8K of Stock

Vuong Trieu, Chairman and CEO, bought 1,044,990 shares of Oncotelic Therapeutics, Inc. at $0.017 a share, worth $17.8K in total on Oct 29, 2026. Shares held after the trade: 95,481,309 (+1.1%).

Value
$17.8K
Shares
1,044,990
Price
$0.0170
Role
Chairman and CEO
Holding change
+1.1%
Trade date
Oct 29, 2026
8:50 AM ET 10-Q
Financial Results Cohen & Steers, Inc. CNS

Cohen & Steers Q3 2026 Results: Net Income $42.2M, Up 1.3% YoY

Cohen & Steers reported a net income attributable to common stockholders of $134.0 million for the nine months ended September 30, 2026, an increase from $118.3 million in the prior year period. Total revenue grew to $455.8 million, driven primarily by higher investment advisory and administration fees, while total assets increased to $979.8 million from $876.7 million at year-end 2025.

Key figure
Net income $42.2M · +1.3% YoY
8:50 AM ET 8-K
Business Update Moleculin Biotech, Inc. MBRX

Moleculin Biotech Business Update

Moleculin Biotech has completed patient dosing in Part A of its pivotal Phase 2/3 MIRACLE trial evaluating Annamycin in combination with cytarabine for relapsed or refractory acute myeloid leukemia (R/R AML). The company remains on track to report comprehensive data from the 90-patient Part A population in the first quarter of 2027, which will inform dose selection for Part B of the trial.

8:49 AM ET 10-Q
Financial Results SouthState Bank Corp SSB

SouthState Bank Q3 2026 Results: Net Income $224M, Down 9.3% YoY

SouthState Bank Corp reported net income of $223.8 million for the third quarter of 2026, a decrease from $246.6 million in the prior year period. Total assets grew to $70.4 billion, driven by a significant increase in non-acquired loans, while the company maintained a strong capital position despite an increase in accumulated other comprehensive loss.

Key figure
Net income $224M · -9.3% YoY
8:46 AM ET 8-K
Financial Results Arbor Realty Trust Inc ABR

Arbor Realty Trust Financial Results

Arbor Realty Trust reported a GAAP net loss of $85.4 million for the third quarter of 2026, significantly down from net income of $38.5 million in the prior year. Due to the challenging market environment, the company has suspended its quarterly cash dividend on common stock to preserve capital and maintain financial flexibility.

8:46 AM ET 8-K
Financial Results Mastech Digital, Inc. MHH

Mastech Digital Financial Results

Mastech Digital reported third quarter 2026 financial results, highlighting its second consecutive quarter of sequential revenue growth driven by momentum in its Data & AI segment. While total revenues declined 13.4% year-over-year to $42.0 million, the Data & AI segment saw a 4.7% sequential increase and a 29% increase in bookings compared to the prior year period.

Term
Q3 2026

“This quarter marks a significant milestone, as we launched the new Mastech brand and our vision of the Knowledge-first Enterprise. We believe enterprises need to codify the knowledge held by their people, customers, and clients to transform with AI. We are seeing enterprises move past AI experimentation. They now want to put their own data and knowledge to work in production, and that is driving our focus on building trusted data foundations, Applied AI solutions, and the specialized talent that our clients need to deliver AI outcomes at scale.”

Nirav Patel, Mastech's President and Chief Executive Officer
8:46 AM ET 10-Q
Financial Results BrightSpring Health Services, Inc. BTSG

BrightSpring Health Services Q3 2026 Results: Net Income $100M, Up 79.3% YoY

BrightSpring Health Services reported total current assets of $2.77 billion as of September 30, 2026, a slight decrease from $2.89 billion at year-end 2025, primarily due to the disposition of assets held for sale. The company maintained a significant cash position of $717.8 million and reported 198,984,612 shares of common stock outstanding as of October 27, 2026.

Key figure
Net income $100M · +79.3% YoY
8:46 AM ET 8-K
Financial Results Red River Bancshares Inc RRBI

Red River Bancshares Financial Results

Red River Bancshares reported record-high quarterly net income of $12.6 million and EPS of $1.90 for the third quarter of 2026. The results were driven by a 3.2% increase in net interest income and growth in both loans and deposits, which reached $2.32 billion and $2.96 billion respectively. The company also completed its New Orleans banking center relocation and continued its organic expansion in the Acadiana market.

Term
Q3 2026
8:43 AM ET 8-K
Business Update Nelnet Inc NNI

Nelnet Business Update

Nelnet, Inc.'s wholly-owned subsidiary, Nelnet Bank, filed its quarterly Consolidated Reports of Condition and Income (Call Report) with the FDIC for the period ended September 30, 2026. The filing serves as a regulatory disclosure update for the bank's financial condition and operations, which are now publicly available on the FDIC website.

Counterparty
FDIC
Term
Q3 2026
8:41 AM ET 10-Q
Financial Results Verra Mobility Corp VRRM

Verra Mobility Q3 2026 Results: Net Income $40.4M, Down 13.8% YoY

Verra Mobility reported a significant increase in cash and cash equivalents to $137.0 million as of September 30, 2026, compared to $65.3 million at year-end 2025. The company is navigating material customer concentration risks, including the termination of a contract with a major Commercial Services customer effective January 2027 and less favorable renewal terms with other key clients.

Key figure
Net income $40.4M · -13.8% YoY
8:37 AM ET 8-K
Financial Results Iradimed Corp IRMD

Iradimed Financial Results

IRADIMED reported record Q3 2026 revenue of $24.2 million, a 14% year-over-year increase driven by the launch of its new 3870 MR IV pump. The company also declared a quarterly cash dividend of $0.20 per share and updated its full-year 2026 revenue guidance to a range of $91.6 million to $93.1 million.

Term
Q3 2026

“We are pleased to report record revenue of $24.2 million for the third quarter, driven by the continued successful launch of our new 3870 MR IV pump. As our manufacturing team gains experience with the new platform while at the same time greatly ramping up production, we began realizing the efficiencies we anticipated with gross margin improving sequentially as expected.”

Roger Susi, President and Chief Executive Officer of Iradimed

“For the fourth quarter of 2026, we expect revenue of $25.0 million to $26.5 million, attaining a $100.0 million revenue run rate while generating GAAP diluted earnings per share of $0.53 to $0.57 and non-GAAP diluted earnings per share of $0.57 to $0.61.”

Roger Susi, President and Chief Executive Officer of Iradimed
8:36 AM ET 8-K
Financial Results Verra Mobility Corp VRRM

Verra Mobility Financial Results

Verra Mobility reported third quarter 2026 financial results with total revenue of $258.9 million and net income of $40.4 million. The company reaffirmed its full-year 2026 guidance and noted record bookings in its Government Solutions segment, despite a 14% revenue decline in Commercial Services. Due to pending leadership transitions, the company did not hold a concurrent earnings conference call.

8:33 AM ET 8-K
Capital Raise OpenWorld, Inc. OPNW

OpenWorld Capital Raise of $3.5M

OpenWorld, Inc. entered into a securities purchase agreement for a $3.5 million registered direct offering with a single institutional investor. The company is selling 2,517,985 shares of common stock at a combined price of $1.39 per share, including accompanying Series A and Series B warrants. Proceeds are intended for real-world asset growth initiatives and general corporate purposes.

Value
$3.5M
Counterparty
Maxim Group LLC
8:33 AM ET 8-K
Stock Buyback Hilton Grand Vacations Inc. HGV

Hilton Grand Vacations Announces $200M Stock Buyback

Hilton Grand Vacations Inc. entered into an accelerated share repurchase (ASR) agreement with Deutsche Bank to repurchase $200 million of its common stock. The company will receive an initial delivery of approximately 4.48 million shares on October 30, 2026, with final settlement expected by December 31, 2026. This transaction is part of the company's previously authorized share repurchase program.

Value
$200M
Counterparty
Deutsche Bank AG, London Branch
Term
through Dec 2026
8:32 AM ET 8-K
Dividend Starwood Credit Real Estate Income Trust

Starwood Credit Real Estate Income Trust Dividend

Starwood Credit Real Estate Income Trust declared monthly cash distributions for October 2026 across its Class S, Class I, and Class E common shares. All classes will receive a gross distribution of $0.1300 per share, payable on or about November 4, 2026, to shareholders of record as of October 30, 2026.

8:32 AM ET 10-Q
Financial Results Colgate Palmolive Co CL

Colgate Palmolive Q3 2026 Results: Net Income $751M, Up 2.2% YoY

Colgate-Palmolive reported net sales of $5,369 million for the quarter ended September 30, 2026, a 4.6% increase over the prior year. While net income attributable to the company rose slightly to $751 million for the quarter, nine-month year-to-date net income decreased from $2,169 million to $2,090 million, primarily due to higher selling, general, and administrative expenses and other net expenses.

Key figure
Net income $751M · +2.2% YoY
8:31 AM ET 8-K
Capacity Expansion TerraVolt Holdings, Inc. GEDC

TerraVolt Holdings Capacity Expansion: $32.3M Investment

TerraVolt Holdings entered into option agreements to acquire 1,077 acres in Cassia County, Idaho, for the development of a 240 MW gas-powered digital infrastructure campus. The company paid a $150,000 option fee for the site, which is designed to operate behind-the-meter to avoid grid interconnection delays. The total purchase price for the land is approximately $32.31 million ($30,000 per acre), payable in a mix of cash and a convertible secured promissory note.

Value
$32.3M
Counterparty
Wickel Land Company LLP
Term
Option expires Oct 2027
8:31 AM ET 8-K
Dividend Oxford Square Capital Corp. OXSQ

Oxford Square Capital Dividend

Oxford Square Capital Corp. declared monthly cash distributions of $0.015 per share for January, February, and March 2027. The company also reported third-quarter 2026 results, including net investment income of $4.9 million and a net asset value of $1.21 per share.

8:31 AM ET 8-K
Partnership Pluri Inc. PLUR

Pluri Partnership with ZEO ScientifiX, Inc.

Pluri Inc. entered into a partnership agreement with ZEO ScientifiX to grant ZEO an exclusive license to manufacture and commercialize Pluri's regenerative medicine portfolio in the United States. In exchange, Pluri will receive a 50% equity stake in ZEO and the right to designate four out of seven board members, while ZEO will receive approximately 9% of Pluri's outstanding common shares.

Counterparty
ZEO ScientifiX, Inc.
8:30 AM ET 8-K
Partnership Zeo ScientifiX, Inc. ZEOX

Zeo ScientifiX Partnership with Pluri Inc.

Zeo ScientifiX entered into a definitive strategic agreement with Pluri Inc. to expand U.S. manufacturing and commercialization of regenerative medicine products. As part of the license-for-equity transaction, Pluri will grant ZEO an exclusive license to its proprietary 3D cell expansion platform in exchange for a 41% equity stake in ZEO and a share swap involving 4% of each company's outstanding stock.

Counterparty
Pluri Inc.
8:28 AM ET 6-K
Financial Results Neo-Concept International Group Holdings Ltd NCI

Neo-Concept International Group Holdings H1 2026 Results: Net Loss of $9.1M

Neo-Concept International Group Holdings reported a net loss of HKD 9.1 million for the first half of 2026, compared to a net income of HKD 2.0 million in the prior year period, driven by a decline in revenue and increased staff and inventory impairment costs. Total assets increased significantly to HKD 166.1 million, largely due to a substantial increase in prepayments to related parties and proceeds from a share placement.

Key figure
Net loss $9.1M
8:27 AM ET 8-K
Financial Results Oppenheimer Holdings Inc OPY

Oppenheimer Holdings Financial Results

Oppenheimer Holdings reported third quarter 2026 revenue of $382.0 million and net income of $5.5 million, down from $21.7 million in the prior year. Results were significantly impacted by a $21.0 million pre-tax expense related to a stock-price-linked employee incentive program following a $12.42 per share increase in the company's stock price during the quarter.

Term
Q3 2026

“The Firm's operating results for the third quarter reflected generally constructive market conditions, although earnings were disappointing due to lower retail trading activity, reduced investment banking volumes and higher expense associated with the increased value of stock appreciation rights resulting from the change in the Company's stock price during the quarter.”

Robert S. Lowenthal, President and CEO
8:24 AM ET 10-Q
Financial Results OmniAb, Inc. OABI ▶ Call

OmniAb Q3 2026 Results: Net Loss of $15.7M, Loss Narrows

OmniAb, Inc. reported total revenue of $31.8 million for the nine months ended September 30, 2026, a significant increase from $10.3 million in the prior year period, primarily driven by license and milestone revenue. Despite the revenue growth, the company recorded a net loss of $29.3 million for the first nine months of 2026, though this was an improvement over the $50.6 million net loss reported for the same period in 2025.

Key figure
Net loss $15.7M
8:19 AM ET 10-Q
Financial Results Oppenheimer Holdings Inc OPY

Oppenheimer Holdings Q3 2026 Results: Net Income $5.46M, Down 74.9% YoY

Oppenheimer Holdings Inc. reported total revenue of $1.28 billion for the first nine months of 2026, up from $1.17 billion in 2025, driven by growth in advisory fees and investment banking. However, net income for the period fell significantly to $12.2 million from $74.0 million, primarily due to a $70 million expense related to a 'cash sweep' program litigation settlement.

Key figure
Net income $5.46M · -74.9% YoY
8:17 AM ET 8-K
M&A Deal Organon & Co. OGN

Organon & M&A Deal with Sun Pharmaceutical Industries Limited

Organon & Co. provided a status update on its pending merger with Sun Pharmaceutical Industries Limited, noting that it has suspended customary earnings calls and press releases due to the transaction. The company furnished supplemental non-GAAP financial metrics for the third quarter of 2026 in lieu of a formal earnings release while the merger remains active.

Counterparty
Sun Pharmaceutical Industries Limited
8:17 AM ET 10-Q
Financial Results Cboe Global Markets, Inc. CBOE ▶ Call

Cboe Global Markets Q3 2026 Results: Net Income $428M, Up 42.4% YoY

Cboe Global Markets, Inc. filed its 10-Q for the period ending September 30, 2026, reporting 104,330,235 shares of common stock outstanding as of October 23, 2026. The filing includes unaudited condensed consolidated financial statements for the three and nine months ended September 30, 2026, and identifies the company as a large accelerated filer.

Key figure
Net income $428M · +42.4% YoY

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.